Labroots

Getting started with NGS-based immune profiling

The use of next-generation sequencing (NGS) technologies to detect B-cell receptor (BCR) or T-cell receptor (TCR) clonotypes ...

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2025 earnings call transcript

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2025 Earnings Call Transcript February 5, 2026 Adaptive Biotechnologies ...

Adaptive Biotechnologies targets 30%+ clonoSEQ test volume growth in 2026 while expanding margins and data partnerships

Q4 2025 earnings call recap: clonoSEQ MRD growth, 2026 revenue guidance, margins, cash burn and risks—read now.

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results

Adaptive Biotechnologies Corporation ("Adaptive Biotechnologies") (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics ...
MarketersMEDIA Newsroom

Integrated Pipeline: Creative Biolabs Synergizes AI Neoantigen Prediction with NeoTCR-T and PD-1 Blockade Strategies

Recently, Creative Biolabs offered a unified framework to accelerate the development of highly specific, evasion-resistant ...
Transparency Market Research

Non-specific Endonuclease Market

Non-specific Endonuclease Market to reach US$ 726.6 Bn by 2036 at 6.5% CAGR, driven by rising biotechnology research, ...

Why Early-Year Planning Matters in Engineering and Development Projects

LAFAYETTE, LA, UNITED STATES, January 16, 2026 /EINPresswire.com/ -- Early planning plays a vital role in engineering ...